Rchr
J-GLOBAL ID:202101018611032803   Update date: Feb. 13, 2024

Jindai Kazuaki

ジンダイ カズアキ | Jindai Kazuaki
Affiliation and department:
Job title: visiting scholar/lecturer
Other affiliations (3):
  • Allm.inc  President office   Consultant
  • Medical corp. Meseikai  Internal Medicine
  • Kyoto University  Healthcare Epidemiology   visiting scholar/lecturer
Research field  (3): Hygiene and public health (non-laboratory) ,  Internal medicine - General ,  Infectious disease
Research keywords  (7): (Re-)Emerging Infectious Diseases ,  Antimicrobial stewardship ,  Quasi-experimental study ,  Preventive medicine ,  COVID-19 ,  Health system ,  Infectious Diseases
Research theme for competitive and other funds  (6):
  • 2022 - 2025 Informed consent in clinical trials with severe state COVID-19 patients: current practice and feasibility of electronic methods
  • 2022 - 2023 Research for G7 Health Ministers' Meeting
  • 2022 - 2023 Building clinical trial platforms for therapeutics and vaccine during pandemic
  • 抗菌薬適性使用に関する政策の医師の処方行動へ与える影響及びその医療経済学的分析
  • 抗菌薬適性使用に関する患者・家族の理解向上のための加算の有用性の評価
Show all
Papers (39):
  • Büchler AC, Haddad Galas M, Buetti N, Alp E, Apisarnthanarak A, Dziekan G, Fabre V, Gottwalt S, Jindai K, Ndoye B, et al. Challenges and success stories of the implementation of infection control and antimicrobial stewardship strategies: proceedings of the 5th Global Ministerial Summit on Patient Safety, 2023. Antimicrobial resistance and infection control. 2024
  • Ishizaki S, Jindai K, Saito H, Oshitani H, Kulstad Gonzalez T. Patient Admission and Mechanical Ventilator Allocation Decision-Making Processes by Frontline Medical Professionals in a Japanese ICU During the COVID-19 Pandemic: A Qualitative Study. Qualitative health research. 2023
  • 大山 裕美子, 保科 ゆい子, 神代 和明, 斎藤 浩輝, 一原 直昭. 重症COVID-19患者の臨床試験への参加経験に関する質的研究. 日本集中治療医学会雑誌. 2023. 30. Suppl.1. S751-S751
  • Kazuaki Jindai, Tim Farley, Quentin Awori, Anaelia-Siya Temu, Fabian Ndenzako, Julia Samuelson. Systematic review: Safety of surgical male circumcision in context of HIV prevention public health programmes [version 2; peer review: 2 approved]. Gates Open Research. 2023
  • Hiroshima G7 Global Health Task Force. Promote global solidarity to advance health-system resilience: proposals for the G7 meetings in Japan. The Lancet. 2023. 401. 10385. 1319-1321
more...
MISC (4):
  • 德本惇奈, 神代和明. COVID-19クラスター対策. 小児内科. 2022. 54. 1
  • 神代 和明, 一原 直昭, 齋藤 浩輝, 鎌田 一宏, 藤谷 茂樹. パンデミック対応型国際臨床研究プラットフォーム:REMAP-CAP. 医学界新聞. 2021. 3412
  • 神代和明, 押谷仁. クラスター対策による感染拡大の防止. 医学のあゆみ. 2021. 276. 1
  • 神代和明, 古瀬祐気, 押谷 仁. 新型コロナウイルス感染症クラスター対策. IASR. 2020. 41
Books (7):
  • 2023年G7に向けたグローバルヘルスに関する提言
    2023
  • COVID-19 Health system response monitor: Japan
    World Health Organization. Regional Office for South-East Asia 2021
  • Nippon AMR One Health Report (NAOR) 2018 (English ver.)
    Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare 2018
  • 薬剤耐性ワンヘルス動向調査 年次報告書 2018
    厚生労働省健康局結核感染症課 2018
  • Nippon AMR One Health Report (NAOR) 2017 (English ver.)
    Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare 2017
more...
Lectures and oral presentations  (31):
  • Patient and public involvement & involvement during health emergency in Japan
    (2024)
  • How can we contribute to developing therapeutics during pandemic? Lesson learned from Japanʼs experience
    (Lecture series @ San Lazaro Hospital, Manila, Philippines 2023)
  • Clinical trial to identify therapeutics during COVID-19 pandemic. Lesson Learned from Japanese experience
    (System Design of Inclusive Society with Infectious Diseases (SDGS-ID) 2023)
  • Challenges and Success of Antibiotic Stewardship in Japan
    (The 5th World Ministerial Summit on Patient Safety in Montreux, Switzerland 2023)
  • Lesson Learned from Investigators of Clinical Trials to Identify Therapeutics for COVID-19: Qualitative Study
    (ID WEEK 2022 2022)
more...
Education (3):
  • 2017 - 2022 Kyoto University Graduate School of Medicine Healthcare Epidemiology
  • 2014 - 2016 Oregon Health & Science University School of Public Health
  • 1998 - 2004 Kanazawa University
Professional career (3):
  • Medical Doctor (Kanazawa University)
  • Master of Public Health (Epidemiology) (Oregon Health & Science University )
  • Doctor of Public Health (Kyoto University, School of Public Health)
Work history (14):
  • 2021/04 - 現在 Tohoku University Graduate School of Medicine
  • 2020/04 - 現在 Kyoto University Graduate School of Medicine and Pubic Health
  • 2020/03 - 現在 The National COVID-19 Cluster Taskfoce
  • 2019/12 - 2020/09 World Health Organization, Kobe Center (WKC)
  • 2019/08 - 2019/12 World Health Organization
Show all
Committee career (3):
  • 2021/01 - 現在 REMAP-CAP Japan Regional Management Committee (RMC)
  • 2019/09 - 現在 American College of Physician (Japan chapter) International Exchange Program Committee
  • 2022/08 - 2023/05 Japan Center for International Exchange Hiroshima G7 Global Health Task Force
Awards (6):
  • 2020/07 - American College of Physician Fellow of American College of Physician (FACP)
  • 2016/12 - Board Certified in Preventive Medicine by the American Board of Preventive Medicine
  • 2015/08 - The 2nd annual Epidemiologic Data Analysis & Interpretation Course Presentation Best presentation
  • 2014/10 - Board Certified in Infectious Diseases by the American Board of Internal Medicine
  • 2012/08 - Board Certified in Intenal Medicine by the American Board of Internal Medicine
Show all
Association Membership(s) (5):
日本臨床疫学会 ,  Society of Healthcare Epidemiology of America ,  Infectious Diseases Society of America ,  American College of Physicians ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page